{"id":11,"date":"2025-10-22T15:36:26","date_gmt":"2025-10-22T14:36:26","guid":{"rendered":"https:\/\/lend-rx.com\/?page_id=11"},"modified":"2025-10-23T17:35:06","modified_gmt":"2025-10-23T16:35:06","slug":"about","status":"publish","type":"page","link":"https:\/\/lend-rx.com\/index.php\/about\/","title":{"rendered":"About Me"},"content":{"rendered":"\n

With a career spanning fundamental investment management<\/strong> and alternative data innovation<\/strong>, I bring a unique combination of healthcare sector expertise<\/strong>, proven stock-picking performance<\/strong>, and advanced data analysis skills<\/strong> aligned with the evolving demands of modern, research-driven investment teams.<\/p>\n\n\n\n

I specialize in bridging fundamental research<\/strong> and quantamental methods<\/strong> to enhance valuation frameworks and generate long-term, risk-adjusted alpha in the healthcare sector. My work reflects a continuous focus on integrating financial insight, scientific understanding, and data science to identify value within complex innovation ecosystems.<\/p>\n\n\n\n

\n\n\n\n

Career Highlights<\/strong><\/h2>\n\n\n\n
\n

\ud83e\udde0 Early Career \u2014 Sell-Side Equity Research (Cr\u00e9dit Lyonnais)<\/strong>

Began as a Sell-Side Analyst<\/strong>, later promoted to Head of Pharma Research<\/strong> at Cr\u00e9dit Lyonnais.
Led healthcare sector coverage, developed fundamental valuation models, and produced investment recommendations for institutional clients.<\/p>\n\n\n\n

\ud83d\udcbc Buy-Side Research and Investment Management (Edmond de Rothschild)<\/strong>

Joined Edmond de Rothschild<\/strong> as a Buy-Side Analyst<\/strong>, specializing in healthcare equities<\/strong>.
Expanded coverage to Special Situations and Event-Driven strategies<\/strong>, combining fundamental research with catalyst-based analysis to identify alpha-generating opportunities.<\/p>\n\n\n\n

\ud83c\udfaf Portfolio Management \u2014 (Edmond de Rothschild Active Strategies)<\/strong>

Managed up to $200M AUM<\/strong> in a long\/short event driven equity strategy with a focus on healthcare.
Delivered consistent outperformance with top-decile, risk-adjusted returns<\/strong>, ranked #2 by Citywire (YE 2014)<\/strong>.<\/p>\n\n\n\n

\ud83d\udca1 Alternative Data and Quantamental Investments<\/strong>

Founded and led a multidisciplinary team (NLP, data science, and engineering) to develop an AI-driven <\/strong> proprietary platform that integrates structured and unstructured data to produce healthcare alternative data and investment insights.
<\/p>\n<\/div>\n\n\n\n

Technical Proficiency<\/strong><\/h2>\n\n\n\n

Experienced in Python<\/strong> and proficient in Bloomberg<\/strong> for financial analysis and valuation modeling.

Strong background in financial model design and automation<\/strong>, integrating quantitative and fundamental approaches to improve consistency, speed, and scalability.

Developed a hybrid LLM automation framework<\/strong> that combines autonomous and supervised agents to extract and structure information from large document sets enhancing data-driven research and valuation across the healthcare and life sciences sectors.<\/p>\n\n\n\n

\n\n\n\n

Recognitions<\/strong><\/h2>\n\n\n\n
\n

New Alpha \/ Morningstar: <\/strong>Emerging Manager of the Year<\/em> (2015)
Citywire A-rated Portfolio Manager <\/strong>(March 2015)
Best Healthcare Analyst \u2013 <\/strong>Stock Picking <\/strong>(2004, RQ)<\/em>
Starmine Ranking:<\/strong> #5 in 2004, #3 in 2003<\/p>\n\n\n\n

\n\n\n\n

Contact<\/strong><\/h2>\n<\/div>\n\n\n\n